NCT00388557View on ClinicalTrials.gov

Effect of Ketoconazole on the Pharmacokinetics of Vinflunine

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

September 30, 2007

Conditions
Cancer
Interventions
DRUG

vinflunine + ketaconazole

vinflunine solution for injection, ketaconazole tablets, vinflunine IV, ketaconazole oral, vinflunine 80 to 320mg/m2 + ketaconazole 400 mg, vinflunine every 3 wks, ketaconazole C1 only, variable duration

Trial Locations (1)

37203

Tennessee Oncology, Pllc, Nashville

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00388557 - Effect of Ketoconazole on the Pharmacokinetics of Vinflunine | Biotech Hunter | Biotech Hunter